{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T21:48:56Z","timestamp":1719784136015},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T00:00:00Z","timestamp":1360800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00108-012-3225-0","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T09:39:02Z","timestamp":1360661942000},"page":"359-365","source":"Crossref","is-referenced-by-count":1,"title":["Schwere Dysphagie und flammende Hautr\u00f6tung bei einem 59-j\u00e4hrigen Patienten"],"prefix":"10.1007","volume":"54","author":[{"given":"M.A.","family":"Zuber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kouba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.E.","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Weller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hrdlicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,14]]},"reference":[{"key":"3225_CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/BOR.0b013e328358ac72","volume":"24","author":"Aggarwal","year":"2012","unstructured":"Aggarwal R, Oddis CV (2012) Therapeutic advances in myositis. Curr Opin Rheumatol 24:635\u2013641","journal-title":"Curr Opin Rheumatol"},{"key":"3225_CR2","doi-asserted-by":"crossref","unstructured":"Amato AA, Barohn RJ (2009) Evaluation and treatment of inflammatory myopathies. J\u00a0Neurol Neurosurg Psychiatry 80:1060\u20131068","DOI":"10.1136\/jnnp.2008.169375"},{"key":"3225_CR3","doi-asserted-by":"crossref","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N\u00a0Engl J Med 292:344\u2013347; 403\u2013407","DOI":"10.1056\/NEJM197502132920706"},{"key":"3225_CR4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","volume":"24","author":"Bunch","year":"1980","unstructured":"Bunch TW (1980) Prednisone and azathioprine for polymyositis: long-term follow-up. Arthritis Rheum 24:45\u201348","journal-title":"Arthritis Rheum"},{"key":"3225_CR5","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Illa I, Dambrosia JM et\u00a0al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N\u00a0Engl J Med 329:1993\u20132000","DOI":"10.1056\/NEJM199312303292704"},{"key":"3225_CR6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"Dalakas","year":"2003","unstructured":"Dalakas M, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"3225_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","volume":"6","author":"Dalakas","year":"2010","unstructured":"Dalakas MC (2010) Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol 6:129\u2013137","journal-title":"Nat Rev Rheumatol"},{"key":"3225_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11940-010-0111-8","volume":"13","author":"Distad","year":"2011","unstructured":"Distad BJ, Amato AA, Weiss MD (2011) Inflammatory Myopathies. Curr Treat Options Neurol 13:119\u2013130","journal-title":"Curr Treat Options Neurol"},{"key":"3225_CR9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2036.2009.04190.x","volume":"31","author":"Ebert","year":"2010","unstructured":"Ebert EC (2010) Review article: the gastrointestinal complications of myositis. Aliment Pharmacol Ther 31:359\u2013365","journal-title":"Aliment Pharmacol Ther"},{"key":"3225_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clineuro.2004.02.024","volume":"107","author":"Ertekin","year":"2004","unstructured":"Ertekin C, Secil Y, Y\u00fcceyar N et\u00a0al (2004) Oropharyngeal dysphagia in polymyositis\/dermatomyositis. Clin Neurol Neurosurg 107:32\u201337","journal-title":"Clin Neurol Neurosurg"},{"key":"3225_CR11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00108-005-1496-4","volume":"46","author":"Genth","year":"2005","unstructured":"Genth E (2005) Entz\u00fcndliche Muskelkrankheiten. Polymyositis, Dermatomyositis und Einschlussk\u00f6rperchenmyositis. Internist 46:1218\u20131232","journal-title":"Internist"},{"key":"3225_CR12","first-page":"CD003653","volume":"8","author":"Gordon","year":"2012","unstructured":"Gordon PA, Winer JB, Hoogendijk JE, Choy EH (2012) Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 8:CD003653","journal-title":"Cochrane Database Syst Rev"},{"key":"3225_CR13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","volume":"48","author":"Gunawardena","year":"2009","unstructured":"Gunawardena H, Betteridge ZE, McHugh NJ (2009) Myositis-specific autoantibodies: their clinical and pathogenic significance in disease. Rheumatology 48:607\u2013612","journal-title":"Rheumatology"},{"key":"3225_CR14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1517\/14656560902913815","volume":"10","author":"Hengstman","year":"2009","unstructured":"Hengstman GJD, Hoogen FHJ van den, Engelen BGM van (2009) Treatment of the inflammatory myopathies: update and practical recommendation. Expert Opin Pharmacother 10:1183\u20131190","journal-title":"Expert Opin Pharmacother"},{"key":"3225_CR15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B et\u00a0al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96\u2013100","journal-title":"Lancet"},{"key":"3225_CR16","doi-asserted-by":"crossref","unstructured":"Hollar CB, Jorizzo JL (2004) Topical tacrolimus 0,1% ointment for refractory skin disease in dermatomyositis: a pilot-study. J\u00a0Dermatol Treat 15:35\u201339","DOI":"10.1080\/09546630310018509"},{"key":"3225_CR17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1755-7682-1-12","volume":"1","author":"Joshi","year":"2008","unstructured":"Joshi D, Mahmood R, Williams P et\u00a0al (2008) Dysphagia secondary to dermatomyositis treated successfully with intravenous immunoglobulin: a case report. Int Arch Med 1:12","journal-title":"Int Arch Med"},{"key":"3225_CR18","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","volume":"9","author":"Koenig","year":"2007","unstructured":"Koenig M, Fritzler MJ, Targoff IN et\u00a0al (2007) Heterogeneity of autoantibodies in 100\u00a0patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 9:R78","journal-title":"Arthritis Res Ther"},{"key":"3225_CR19","first-page":"938","volume":"74","author":"Lemos","year":"2008","unstructured":"Lemos EM, Santoro PP, Tavares RA et\u00a0al (2008) Oropharyngeal dysphagia in dermatomyositis: case report and literature review. Braz J Otolaryngol 74:938\u2013940","journal-title":"Braz J Otolaryngol"},{"key":"3225_CR20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"Levine","year":"2005","unstructured":"Levine TD (2005) Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 52:601\u2013607","journal-title":"Arthritis Rheum"},{"key":"3225_CR21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/rheumatology\/keh499","volume":"44","author":"Majithia","year":"2005","unstructured":"Majithia V, Harisdangkul V (2005) Mycophenolate mofetil (Cellcept): an alternative therapy for autoimmune inflammatory myopathy. Rheumatology 44:386\u2013389","journal-title":"Rheumatology"},{"key":"3225_CR22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","volume":"7","author":"Mammen","year":"2011","unstructured":"Mammen AL (2011) Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neur 7:343\u2013354","journal-title":"Nat Rev Neur"},{"key":"3225_CR23","unstructured":"Marie I, Hachulla E, Levesque H et\u00a0al (1999) Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J\u00a0Rheumatol 26:2706\u20132709"},{"key":"3225_CR24","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/acr.20325","volume":"62","author":"Marie","year":"2010","unstructured":"Marie I, Menard JF, Hatron PY et\u00a0al (2010) Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis. A series of 73\u00a0patients. Arthritis Care Res 62:1748\u20131755","journal-title":"Arthritis Care Res"},{"key":"3225_CR25","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/j.lpm.2010.12.012","volume":"40","author":"Marie","year":"2011","unstructured":"Marie I (2011) Therapy of polymyositis and dermatomyositis. Presse Med 40:e257\u2013e270","journal-title":"Presse Med"},{"key":"3225_CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00296-006-0168-6","volume":"27","author":"Mii","year":"2006","unstructured":"Mii S, Niiyama S, Kusunoki M et\u00a0al (2006) Cyclosporine\u00a0A as treatment of esophageal involvement in dermatomyositis. Rheumatol Int 27:183\u2013185","journal-title":"Rheumatol Int"},{"key":"3225_CR27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4065\/82.4.441","volume":"82","author":"Oh","year":"2007","unstructured":"Oh TH, Brumfield KA, Hoskin TL et\u00a0al (2007) Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62\u00a0patients. Mayo Clin Proc 82:441\u2013447","journal-title":"Mayo Clin Proc"},{"key":"3225_CR28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2169\/internalmedicine.46.0068","volume":"46","author":"Otao","year":"2007","unstructured":"Otao G, Yamashita S, Kyoraku I et\u00a0al (2007) Dysphagia due to inflammation of oral muscles as the first symptom of dermatomyositis. Intern Med 46:923\u2013924","journal-title":"Intern Med"},{"key":"3225_CR29","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","volume":"353","author":"Oddis","year":"1999","unstructured":"Oddis CV, Sciurba FC, Elmagd KA et\u00a0al (1999) Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 353:1762\u20131763","journal-title":"Lancet"},{"key":"3225_CR30","doi-asserted-by":"crossref","unstructured":"Ramachandran RB, Swash M (2004) Pharyngeal dysphagia in dermatomyositis: response to cyclophosphamide. J\u00a0Clin Neuromuscul Dis 5:166\u2013167","DOI":"10.1097\/00131402-200403000-00008"},{"key":"3225_CR31","doi-asserted-by":"crossref","unstructured":"Schoser B (2009) Inflammatorische Myopathien. Z\u00a0Rheumatologie 68:665\u2013677","DOI":"10.1007\/s00393-009-0511-x"},{"key":"3225_CR32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00063-005-1010-8","volume":"100","author":"Seiberlich","year":"2005","unstructured":"Seiberlich B, Hunzelmann N, Roers A et\u00a0al (2005) Das Jo-1-Syndrom und seine klinischen Manifestationen. Medizinische Klinik 100:137\u2013142","journal-title":"Medizinische Klinik"},{"key":"3225_CR33","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/ken029","volume":"47","author":"Sheehan","year":"2008","unstructured":"Sheehan NJ (2008) Dysphagia and other manifestations of oesophageal involvement in the musculoskeletal diseases. Rheumatology 47:746\u2013752","journal-title":"Rheumatology"},{"key":"3225_CR34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(71)80005-3","volume":"1","author":"Sokoloff","year":"1971","unstructured":"Sokoloff MC, Goldberg LS, Pearson CM (1971) Treatment of corticosteroid-resistant polymyositis with methotrexate. Lancet 1:14\u201316","journal-title":"Lancet"},{"key":"3225_CR35","doi-asserted-by":"crossref","unstructured":"Stoltenburg-Didinger-G (2009) Dermatomyositis. Z\u00a0Rheumatol 68:287\u2013294","DOI":"10.1007\/s00393-008-0398-y"},{"key":"3225_CR36","unstructured":"Tanimoto K, Nakano K, Kano S et\u00a0al (1995) Classification criteria for polymyositis and dermatomyositis. J\u00a0Rheumatol 22:668\u2013674"},{"key":"3225_CR37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","volume":"29","author":"Venkovsky","year":"2009","unstructured":"Venkovsky J, Jarosova K, Machacek S et\u00a0al (2009) Cyclosporine\u00a0A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 29:95\u2013102","journal-title":"Scand J Rheumatol"},{"key":"3225_CR38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nmd.2010.03.011","volume":"20","author":"Vlekkert","year":"2010","unstructured":"Vlekkert J van de, Hoogendijk JE, Haan RJ de et\u00a0al (2010) Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial. Neuromuscul Disord 20:382\u2013389","journal-title":"Neuromuscul Disord"},{"key":"3225_CR39","doi-asserted-by":"crossref","unstructured":"Weis J, Nolte K (2009) Myopathien, Myositiden, Vaskulitiden mit Muskelbeteiligung. Welchen Beitrag leistet die Histopathologie? Z\u00a0Rheumatol 68:459\u2013464","DOI":"10.1007\/s00393-009-0455-1"},{"key":"3225_CR40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/gut.52.4.471","volume":"52","author":"Williams","year":"2003","unstructured":"Williams RB, Grehan MJ, Hersch M et\u00a0al (2003) Biomechanics, diagnosis, and treatment outcome in inflammatory myopathy presenting as oropharyngeal dysphagia. Gut 52:471\u2013478","journal-title":"Gut"},{"key":"3225_CR41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","volume":"46","author":"Yamasaki","year":"2007","unstructured":"Yamasaki Y, Yamada H, Yamasaki M et\u00a0al (2007) Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis. Rheumatology 46:124\u2013130","journal-title":"Rheumatology"},{"key":"3225_CR42","doi-asserted-by":"crossref","unstructured":"Yu Z, Lennon VA (1999) Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune disease. N\u00a0Engl J Med 341:57\u201358","DOI":"10.1056\/NEJM199907013410115"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-012-3225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-012-3225-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-012-3225-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:17:34Z","timestamp":1558585054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-012-3225-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["3225"],"URL":"https:\/\/doi.org\/10.1007\/s00108-012-3225-0","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}